Breadcrumb Home News Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment September 29, 2021 JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment. Previous News MN Department of Health Expands Virus Testing in the Twin Cities CRMC regains status as Level III Trauma Center Wastewater monitoring updates to add new capabilities beyond COVID-19 and Twin Cities
